Innovation & Research
Wednesday, December 2, 2020
Inventor and assistive technology researcher Rory Cooper will take on a first-ever role to foster collaborations between STEM disciplines and the health sciences.
Tuesday, December 1, 2020
Pitt and Pittsburgh have long fought HIV and AIDS. On this World AIDS Day, learn about some of the efforts to conquer the disease.
Tuesday, November 24, 2020
The older you get, the more slowly you heal, and there are a number of reasons why. Matthew Steinhauser, associate professor of medicine, explains for The Conversation.
Tuesday, November 24, 2020
Pittsburgh is one of more than 100 trial sites for a vaccine being developed by AstraZeneca and Oxford. The vaccine was shown to be highly effective at combating COVID-19 in a preliminary analysis.
Monday, November 23, 2020
Experts from the Swanson School of Engineering, the School of Computing and Information and the Institute for Cyber Law, Policy, and Security join a new consortium to produce methods, standards and tools to address complex cybersecurity vulnerabilities in manufacturing.
Tuesday, November 17, 2020
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
Friday, November 13, 2020
When sushi rice is compressed, it sticks to the food it surrounds. A new study from Pitt engineers has found the same can be said for the mechanical properties of mucus.
Thursday, November 12, 2020
A nonpartisan team led by Leslie Marshall in Pitt’s Center for Sustainable Business has created a roadmap for climate-friendly industrial growth over the next decade to add jobs and economic prospects across the Ohio Valley.
Monday, November 9, 2020
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
Thursday, November 5, 2020
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.